Does Dapagliflozin Regress Left Ventricular Hypertrophy In Patients With Type 2 Diabetes?

NCT02956811 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes
Left Ventricular Hypertrophy

Interventions

DRUG: Dapagliflozin
DRUG: Placebo

Sponsor

University of Dundee

Collaborators

[object Object]
[object Object]